
Overview
Rifaquat Rahman is a Radiation Oncologist in Boston, Massachusetts. Dr. Rahman is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Glioblastoma, Astrocytoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Vitrectomy.
His clinical research consists of co-authoring 77 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Small Cell Lung Cancer (SCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis Street, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Womens Physicians Organization Inc
Ayal Aizer is a Radiation Oncologist in Boston, Massachusetts. Dr. Aizer has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Prostatectomy, and Gamma Knife Radiosurgery. Dr. Aizer is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Rahman isElite. Learn about Astrocytoma.
- GlioblastomaDr. Rahman isElite. Learn about Glioblastoma.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Rahman isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Rahman isDistinguished. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered RosettesDr. Rahman isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- EpendymomaDr. Rahman isDistinguished. Learn about Ependymoma.
- GliomaDr. Rahman isDistinguished. Learn about Glioma.
- Gliomatosis CerebriDr. Rahman isDistinguished. Learn about Gliomatosis Cerebri.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Lung AdenocarcinomaDr. Rahman isAdvanced. Learn about Lung Adenocarcinoma.
- NeuroepitheliomaDr. Rahman isAdvanced. Learn about Neuroepithelioma.
- Pleuropulmonary BlastomaDr. Rahman isAdvanced. Learn about Pleuropulmonary Blastoma.
- Squamous Cell Lung CarcinomaDr. Rahman isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Acoustic NeuromaDr. Rahman isExperienced. Learn about Acoustic Neuroma.
- Anal CancerDr. Rahman isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Rahman isExperienced. Learn about Bone Tumor.
- Brain Stem CancerDr. Rahman isExperienced. Learn about Brain Stem Cancer.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- EGFR Positive Lung CancerDr. Rahman isExperienced. Learn about EGFR Positive Lung Cancer.

